NCT07164352

Brief Summary

This study aims to evaluate the effects of supervised breathing exercises on pain, dyspnea, and functionality in terminal-stage cancer patients receiving palliative care. Participants in the intervention group receive diaphragmatic and pursed-lip breathing exercises under the guidance of a physiotherapist, while the control group receives only an educational brochure. The study compares pre- and post-intervention outcomes between both groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 4, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2025

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

May 23, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 10, 2025

Completed
Last Updated

September 10, 2025

Status Verified

September 1, 2025

Enrollment Period

9 months

First QC Date

May 23, 2025

Last Update Submit

September 7, 2025

Conditions

Keywords

Palliative CareTerminal Stage CancerBreathing Exercises

Outcome Measures

Primary Outcomes (2)

  • dyspnea

    Dyspnea severity will be assessed using the Edmonton Symptom Assessment System - revised (ESAS-r) dyspnea item. This is a numeric rating scale ranging from 0 to 10, where 0 indicates no shortness of breath and 10 indicates the worst possible shortness of breath. The outcome will evaluate changes in dyspnea severity following a structured breathing exercise intervention.

    From enrollment to the end of treatment at 1 weeks

  • Functionality

    Functionality will be measured using the Edmonton Symptom Assessment System - revised (ESAS-r) physical well-being domain. The ESAS-r is a validated self-report instrument in which patients rate symptom severity on a scale from 0 to 10, with 0 indicating no impairment and 10 indicating the worst possible level of functional impairment. This outcome assesses changes in participants' ability to perform daily activities such as walking, dressing, and self-care.

    From enrollment to the end of treatment at 1 weeks

Study Arms (2)

Diaphragmatic and pursed-lip breathing exercises supervised by a physiotherapist

EXPERIMENTAL

Participants in this arm receive supervised breathing exercises performed with a physiotherapist, focusing on diaphragmatic and pursed-lip breathing techniques.

Behavioral: Breathing Exercises

Brochure Education Only

ACTIVE COMPARATOR

Participants in this arm receive an informational brochure that explains breathing exercises, but no supervised exercise is provided.

Behavioral: Informational Brochure

Interventions

Diaphragmatic and pursed-lip breathing exercises supervised by a physiotherapist.

Diaphragmatic and pursed-lip breathing exercises supervised by a physiotherapist

A brochure providing education about breathing exercises for cancer patients.

Brochure Education Only

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients receiving palliative care, who are part of this treatment process and considered eligible for the study.
  • Patients diagnosed with Stage 4 cancer, included in the study due to their advanced cancer stage.
  • Patients with oxygen saturation levels below 95% in room air, who are deemed appropriate for monitoring respiratory function due to this condition.
  • Participants must be able to effectively communicate during the study period.
  • Individuals who agree to participate in the study must provide written or verbal consent, which is a mandatory criterion for ethical compliance.

You may not qualify if:

  • Patients who are unconscious and unable to participate in the study. Individuals under the age of 18.
  • Patients dependent on a ventilator.
  • Patients with serious health issues, such as uncontrolled hypertension and dyspnea.
  • Patients with other significant health problems that prevent participation in the research program.
  • Patients with medical conditions requiring drainage treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eyupsultan State Hospital

Istanbul, 34500, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Breathing Exercises

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Officials

  • Yaşar Gül BALTACI, Prof. Dr.

    İstanbul Atlas University, Department of Physical Medicine and Rehabilitation

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

May 23, 2025

First Posted

September 10, 2025

Study Start

August 4, 2024

Primary Completion

May 15, 2025

Study Completion

May 15, 2025

Last Updated

September 10, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

This clinical trial evaluates the effects of structured respiratory exercises on pain, dyspnea, and physical functionality in terminal-stage cancer patients under palliative care. It is a single-arm interventional study with pre- and post-intervention assessments. Participants perform pursed-lip and diaphragmatic breathing exercises under physiotherapist supervision for one week. The primary outcomes are changes in pain and dyspnea, measured using ESAS-r and CDS. Secondary outcomes include functional status assessed via standardized tools. Data are collected at baseline and after the intervention. The study follows the Declaration of Helsinki and has received institutional ethical approval. Results aim to support the use of non-pharmacological methods in enhancing the quality of life for patients in end-of-life care.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
The intervention will be applied for 1 week per participant. Respiratory exercises will be conducted daily for 5 consecutive days. Baseline and post-intervention assessments will be performed at the beginning and end of the week, respectively.
Access Criteria
De-identified individual participant data (IPD) may be made available upon reasonable request for academic or research purposes. Access requires submission of a detailed proposal and prior approval by the study investigator. Requests can be sent to yildiz.fatmanur@hotmail.com.

Locations